首页 > 最新文献

Arhiv za Farmaciju最新文献

英文 中文
Self-assembled carriers as drug delivery systems: Current characterization challenges and future prospects 自组装载体作为药物递送系统:当前表征、挑战和未来前景
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.5937/arhfarm73-46975
Ivana Pantelić, Tanja Ilić, Ines Nikolić, Snežana Savić
A review of recent publications reveals an increased interest in the so-called self-assembled carriers and their applicability in drug delivery via various routes of administration. Self-assembly denotes the process of rather spontaneous formation of ordered aggregates (sometimes under specific conditions-e.g., pH, temperature, ionic strength), via diverse interactions. This process, seen in many naturally occurring substances (polysaccharides, proteins, lipids), has inspired researchers to synthetize innovative self-assembling materials or combinations of existing ones. This paper provides a review of the recently investigated self-assembling materials and the carriers they form, often belonging to the sphere of pharmaceutical nanotechnology. Self-assembled carriers may provide enhanced stability, more efficient encapsulation and/or controlled delivery of active pharmaceutical ingredients. However, the diversity of geometries obtained (spheres, polyhedrals, ellipses, discs, porous structures, etc.) presents a significant characterization challenge, often requiring the application of several complementary techniques for proper evaluation of carrier size and morphology. Commonly utilized characterization techniques for investigating physico-chemical and certain biopharmaceutical properties are discussed, along with their advantages and disadvantages. Finally, the authors offer their critical opinion on the outlook of self-assembled drug carriers.
对最近出版物的回顾显示,人们对所谓的自组装载体及其通过各种给药途径给药的适用性越来越感兴趣。自组装是指有序聚集体相当自发地形成的过程(有时在特定条件下,例如:(pH,温度,离子强度),通过不同的相互作用。这一过程在许多自然产生的物质(多糖、蛋白质、脂类)中都可以看到,它激发了研究人员合成创新的自组装材料或现有材料的组合。本文综述了近年来研究的自组装材料及其形成的载体,这些材料通常属于药物纳米技术领域。自组装载体可提供活性药物成分的增强稳定性、更有效的封装和/或控制递送。然而,所获得的几何形状的多样性(球体、多面体、椭圆、圆盘、多孔结构等)对表征提出了重大挑战,通常需要应用几种互补技术来适当评估载流子的大小和形态。讨论了用于研究物理化学和某些生物制药性质的常用表征技术,以及它们的优缺点。最后,对自组装药物载体的发展前景提出了自己的看法。
{"title":"Self-assembled carriers as drug delivery systems: Current characterization challenges and future prospects","authors":"Ivana Pantelić, Tanja Ilić, Ines Nikolić, Snežana Savić","doi":"10.5937/arhfarm73-46975","DOIUrl":"https://doi.org/10.5937/arhfarm73-46975","url":null,"abstract":"A review of recent publications reveals an increased interest in the so-called self-assembled carriers and their applicability in drug delivery via various routes of administration. Self-assembly denotes the process of rather spontaneous formation of ordered aggregates (sometimes under specific conditions-e.g., pH, temperature, ionic strength), via diverse interactions. This process, seen in many naturally occurring substances (polysaccharides, proteins, lipids), has inspired researchers to synthetize innovative self-assembling materials or combinations of existing ones. This paper provides a review of the recently investigated self-assembling materials and the carriers they form, often belonging to the sphere of pharmaceutical nanotechnology. Self-assembled carriers may provide enhanced stability, more efficient encapsulation and/or controlled delivery of active pharmaceutical ingredients. However, the diversity of geometries obtained (spheres, polyhedrals, ellipses, discs, porous structures, etc.) presents a significant characterization challenge, often requiring the application of several complementary techniques for proper evaluation of carrier size and morphology. Commonly utilized characterization techniques for investigating physico-chemical and certain biopharmaceutical properties are discussed, along with their advantages and disadvantages. Finally, the authors offer their critical opinion on the outlook of self-assembled drug carriers.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134982050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Mediterranean diet and lifestyle 地中海饮食和生活方式
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.5937/arhfarm73-45492
Silvia García-Hernández, M. Monserrat-Mesquida, Josep A Tur, C. Bouzas
The Mediterranean Diet (MedDiet) is characterized by a high intake of fruit, vegetables, whole grains, legumes, and olive oil, moderate consumption of poultry and fish, and a limited intake of red meat and minimal processed foods. It has been associated with many health benefits, including the prevention and management of metabolic syndrome, diabetes, cardiovascular disease, neurodegenerative diseases, and certain types of cancer, as well as increased longevity and reduced risk of mortality. The protective effects of the MedDiet are related to its antioxidant and anti-inflammatory properties. The MedDiet is not only a health-promoting dietary pattern, but it is also environmentally sustainable, showing a negative correlation with greenhouse gas emissions, among other environmental indicators. In addition to the MedDiet, the Mediterranean lifestyle, which involves regular physical activity, adequate rest, and socializing during meals, has also been linked to beneficial health outcomes. Preventive strategies for noncommunicable diseases should focus on promoting the Mediterranean lifestyle and implementing early detection and prevention programs, at both individual and social levels.
地中海饮食(MedDiet)的特点是大量摄入水果、蔬菜、全谷物、豆类和橄榄油,适量食用家禽和鱼类,少量摄入红肉和少量加工食品。它与许多健康益处有关,包括预防和管理代谢综合征、糖尿病、心血管疾病、神经退行性疾病和某些类型的癌症,以及延长寿命和降低死亡风险。MedDiet的保护作用与其抗氧化和抗炎特性有关。MedDiet不仅是一种促进健康的饮食模式,而且在环境上也是可持续的,在其他环境指标中,它与温室气体排放呈负相关。除了MedDiet,地中海式的生活方式,包括有规律的体育锻炼、充足的休息和用餐时的社交活动,也与有益的健康结果有关。非传染性疾病的预防战略应侧重于促进地中海生活方式,并在个人和社会层面实施早期发现和预防方案。
{"title":"The Mediterranean diet and lifestyle","authors":"Silvia García-Hernández, M. Monserrat-Mesquida, Josep A Tur, C. Bouzas","doi":"10.5937/arhfarm73-45492","DOIUrl":"https://doi.org/10.5937/arhfarm73-45492","url":null,"abstract":"The Mediterranean Diet (MedDiet) is characterized by a high intake of fruit, vegetables, whole grains, legumes, and olive oil, moderate consumption of poultry and fish, and a limited intake of red meat and minimal processed foods. It has been associated with many health benefits, including the prevention and management of metabolic syndrome, diabetes, cardiovascular disease, neurodegenerative diseases, and certain types of cancer, as well as increased longevity and reduced risk of mortality. The protective effects of the MedDiet are related to its antioxidant and anti-inflammatory properties. The MedDiet is not only a health-promoting dietary pattern, but it is also environmentally sustainable, showing a negative correlation with greenhouse gas emissions, among other environmental indicators. In addition to the MedDiet, the Mediterranean lifestyle, which involves regular physical activity, adequate rest, and socializing during meals, has also been linked to beneficial health outcomes. Preventive strategies for noncommunicable diseases should focus on promoting the Mediterranean lifestyle and implementing early detection and prevention programs, at both individual and social levels.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resource management in HPLC: Unveiling a green face of pharmaceutical analysis 高效液相色谱中的资源管理:揭示药物分析的绿色面孔
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.5937/arhfarm73-43479
Jevrem Stojanović, Jovana Krmar, Biljana Otašević, A. Protić
High-pressure liquid chromatography (HPLC) is a technique of paramount importance in the analysis of pharmaceuticals because of its ability to separate moderately polar to less polar compounds, such as drugs and related substances.High-pressure liquid chromatography (HPLC) is a technique of paramount importance in the analysis of pharmaceuticals because of its ability to separate moderately polar to less polar compounds, such as drugs and related substances. The concept of green analytical chemistry (GAC) aims to provide more environmentally friendly and safer analytical methods in terms of reagents, energy, and waste. One of the major challenges of GAC is to find an appropriate approach to evaluate the greenness of analytical methods. An extension of GAC, called white analytical chemistry (WAC), has been introduced to consider not only environmental friendliness, but also other aspects that contribute to the sustainability of methods, such as analytical and economic or practical efficiency. HPLC methods are intrinsically not green, due to the high consumption of toxic organic solvents and the resulting generation of large amounts of toxic waste. Fortunately, there are many approaches to overcome the non-green character of HPLC methods. In this article, various modifications of the HPLC methods that increase its environmental friendliness are presented, as well as the various tools used to evaluate environmental friendliness. In addition, the new concept of white analytical chemistry is presented.
高压液相色谱法(HPLC)是一种在药物分析中至关重要的技术,因为它能够分离中极性到低极性的化合物,如药物和相关物质。高压液相色谱法(HPLC)是一种在药物分析中至关重要的技术,因为它能够分离中极性到低极性的化合物,如药物和相关物质。绿色分析化学(GAC)的概念旨在提供在试剂、能源和废物方面更环保、更安全的分析方法。GAC的主要挑战之一是找到一个合适的方法来评估分析方法的绿色。GAC的延伸,称为白色分析化学(WAC),已经被引入,不仅考虑环境友好,而且考虑其他方面,有助于方法的可持续性,如分析和经济或实际效率。高效液相色谱法本质上是不绿色的,因为它消耗大量的有毒有机溶剂,产生大量的有毒废物。幸运的是,有许多方法可以克服高效液相色谱法的非绿色特性。在这篇文章中,介绍了各种改进的高效液相色谱方法,以增加其环境友好性,以及各种用于评估环境友好性的工具。此外,还提出了白色分析化学的新概念。
{"title":"Resource management in HPLC: Unveiling a green face of pharmaceutical analysis","authors":"Jevrem Stojanović, Jovana Krmar, Biljana Otašević, A. Protić","doi":"10.5937/arhfarm73-43479","DOIUrl":"https://doi.org/10.5937/arhfarm73-43479","url":null,"abstract":"High-pressure liquid chromatography (HPLC) is a technique of paramount importance in the analysis of pharmaceuticals because of its ability to separate moderately polar to less polar compounds, such as drugs and related substances.High-pressure liquid chromatography (HPLC) is a technique of paramount importance in the analysis of pharmaceuticals because of its ability to separate moderately polar to less polar compounds, such as drugs and related substances. The concept of green analytical chemistry (GAC) aims to provide more environmentally friendly and safer analytical methods in terms of reagents, energy, and waste. One of the major challenges of GAC is to find an appropriate approach to evaluate the greenness of analytical methods. An extension of GAC, called white analytical chemistry (WAC), has been introduced to consider not only environmental friendliness, but also other aspects that contribute to the sustainability of methods, such as analytical and economic or practical efficiency. HPLC methods are intrinsically not green, due to the high consumption of toxic organic solvents and the resulting generation of large amounts of toxic waste. Fortunately, there are many approaches to overcome the non-green character of HPLC methods. In this article, various modifications of the HPLC methods that increase its environmental friendliness are presented, as well as the various tools used to evaluate environmental friendliness. In addition, the new concept of white analytical chemistry is presented.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Stability evaluation of emulsion-based topical preparations: A valuable potential of dynamicmechanical thermoanalysis (DMTA) test as a rapid rheological alternative to conventional freezethaw test 乳基外用制剂的稳定性评价:动态机械热分析(DMTA)试验作为常规冻融试验的快速流变替代方法的宝贵潜力
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.5937/arhfarm73-46319
Nebojša Cekić, Sanela Savić, Snežana Savić
The assessment of stability in emulsion-based topical preparations can be approached through real-time monitoring and/or accelerated methods, drawing predictions from pertinent stability-related physicochemical parameters. Ensuring the robustness and durability of topical products during storage, transport, and application necessitates thorough stability testing. However, due to the diversity of emulsion types and their intended use, there is no universal standard test, placing the liability on formulators/manufacturer to tailor appropriate assessments. Notably, topical emulsions, particularly cosmetic variants, often exhibit impressive stability with extended shelf lives. Nonetheless, evaluating their stability and decision-making remain challenging and time-consuming in industrial contexts. This underscores the demand for alternative testing protocols that expedite stability assessments and predict emulsion-based product stability accurately. This article comprehensively surveys literature, enriched with practical insights, exploring core mechanisms behind emulsion stability and prevention of instability. The discussion encompasses diverse approaches to stability assessment, revealing methodologies and parameters under examination during testing. Particular focus is placed on the dynamic-mechanical thermoanalysis (DMTA) method explored as a rapid, rheologically-based alternative to the conventional freeze-thaw test, emphasizing its usefulness for expediting the stability evaluation of emulsion-based topical preparations.
乳基外用制剂的稳定性评估可以通过实时监测和/或加速方法来实现,从相关的稳定性相关的物理化学参数中得出预测。为了确保局部产品在储存、运输和应用过程中的坚固性和耐久性,需要进行彻底的稳定性测试。然而,由于乳液类型及其预期用途的多样性,没有通用的标准测试,因此配方商/制造商有责任定制适当的评估。值得注意的是,局部乳剂,特别是化妆品变体,通常表现出令人印象深刻的稳定性和延长的保质期。然而,在工业环境中,评估它们的稳定性和决策仍然具有挑战性和耗时。这强调了对替代测试方案的需求,以加快稳定性评估和准确预测乳化基产品的稳定性。本文综合文献资料,丰富了实践见解,探讨了乳状液稳定性和预防失稳的核心机制。讨论了稳定性评估的各种方法,揭示了测试过程中检查的方法和参数。特别关注动态机械热分析(DMTA)方法作为传统冻融试验的一种快速、基于流变学的替代方法,强调其在加速乳基外用制剂稳定性评估方面的实用性。
{"title":"Stability evaluation of emulsion-based topical preparations: A valuable potential of dynamicmechanical thermoanalysis (DMTA) test as a rapid rheological alternative to conventional freezethaw test","authors":"Nebojša Cekić, Sanela Savić, Snežana Savić","doi":"10.5937/arhfarm73-46319","DOIUrl":"https://doi.org/10.5937/arhfarm73-46319","url":null,"abstract":"The assessment of stability in emulsion-based topical preparations can be approached through real-time monitoring and/or accelerated methods, drawing predictions from pertinent stability-related physicochemical parameters. Ensuring the robustness and durability of topical products during storage, transport, and application necessitates thorough stability testing. However, due to the diversity of emulsion types and their intended use, there is no universal standard test, placing the liability on formulators/manufacturer to tailor appropriate assessments. Notably, topical emulsions, particularly cosmetic variants, often exhibit impressive stability with extended shelf lives. Nonetheless, evaluating their stability and decision-making remain challenging and time-consuming in industrial contexts. This underscores the demand for alternative testing protocols that expedite stability assessments and predict emulsion-based product stability accurately. This article comprehensively surveys literature, enriched with practical insights, exploring core mechanisms behind emulsion stability and prevention of instability. The discussion encompasses diverse approaches to stability assessment, revealing methodologies and parameters under examination during testing. Particular focus is placed on the dynamic-mechanical thermoanalysis (DMTA) method explored as a rapid, rheologically-based alternative to the conventional freeze-thaw test, emphasizing its usefulness for expediting the stability evaluation of emulsion-based topical preparations.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134981813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current role of tribological tests: Striving for full characterization of medicinal and cosmetic products 摩擦学试验的当前作用:争取医药和化妆品的充分表征
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.5937/arhfarm73-43515
Anđela Tošić, Tijana Stankovic, T. Ilić, S. Savić, I. Pantelić
Tribology investigates the events that happen on the surfaces of two substances/objects that are in direct or indirect contact through assessing friction, lubrication and/or wear. In particular, friction measurements could provide the information on the textural characteristics of (per)oral pharmaceutical preparations and contribute to the understanding of palatability. On the other hand, tribological tests have been more intensively used to characterize topical preparations (pharmaceutical, cosmetic), giving a thorough insight into the tactile and texture properties of these preparations. However, these tests are often combined with rheological, textural, and certain biophysical approaches. Additionally, the materials used for constructing artificial joints and articular cartilages are true tribological systems, developed and optimized in order to have properties that resemble the natural ones. Since tribological studies can be used to assess a wide range of drug dosage forms and products in general, the equipment used may be quite diverse. Accordingly, a special section of this work is committed to the description of the testing equipment's specifications and the applied protocols. The investigation of recently regulatory discovered phenomena, such as transformation/metamorphosis of the vehicle/base of topical preparations, have brought tribology back into focus as a potential assessment method.
摩擦学通过评估摩擦、润滑和/或磨损,研究直接或间接接触的两种物质/物体表面发生的事件。特别是,摩擦测量可以提供有关(每)口服药物制剂的质地特征的信息,有助于了解适口性。另一方面,摩擦学测试已被更广泛地用于表征局部制剂(药物,化妆品),从而深入了解这些制剂的触觉和质地特性。然而,这些测试通常与流变学、结构和某些生物物理方法相结合。此外,用于构建人工关节和关节软骨的材料是真正的摩擦学系统,开发和优化的目的是为了具有与天然材料相似的性能。由于摩擦学研究通常可用于评估范围广泛的药物剂型和产品,因此所使用的设备可能相当多样化。因此,这项工作的一个特殊部分致力于描述测试设备的规格和应用协议。对最近发现的监管现象的调查,如局部制剂的载体/基础的转化/变态,使摩擦学作为一种潜在的评估方法重新受到关注。
{"title":"Current role of tribological tests: Striving for full characterization of medicinal and cosmetic products","authors":"Anđela Tošić, Tijana Stankovic, T. Ilić, S. Savić, I. Pantelić","doi":"10.5937/arhfarm73-43515","DOIUrl":"https://doi.org/10.5937/arhfarm73-43515","url":null,"abstract":"Tribology investigates the events that happen on the surfaces of two substances/objects that are in direct or indirect contact through assessing friction, lubrication and/or wear. In particular, friction measurements could provide the information on the textural characteristics of (per)oral pharmaceutical preparations and contribute to the understanding of palatability. On the other hand, tribological tests have been more intensively used to characterize topical preparations (pharmaceutical, cosmetic), giving a thorough insight into the tactile and texture properties of these preparations. However, these tests are often combined with rheological, textural, and certain biophysical approaches. Additionally, the materials used for constructing artificial joints and articular cartilages are true tribological systems, developed and optimized in order to have properties that resemble the natural ones. Since tribological studies can be used to assess a wide range of drug dosage forms and products in general, the equipment used may be quite diverse. Accordingly, a special section of this work is committed to the description of the testing equipment's specifications and the applied protocols. The investigation of recently regulatory discovered phenomena, such as transformation/metamorphosis of the vehicle/base of topical preparations, have brought tribology back into focus as a potential assessment method.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid function disorders 甲状腺功能障碍
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.5937/arhfarm72-39952
M. Stojković
Thyroid function disorders are the most common endocrine disorders in humans. They are frequently diagnosed, with prevalence varying between 2 and 6%, and a female to male ratio of up to 10:1. Disorders of thyroid function in the narrower sense are presented by its hyperactivity or underactivity, although there are conditions that lead to an increased concentration of thyroid hormones, without its increased activity. In iodine-sufficient regions, the most common cause of hyperthyroidism, as well as hypothyroidism, is an autoimmune disease of the thyroid. For hyperthyroidism, it is Graves' disease, with typical symptoms and signs of hypermetabolism. The diagnosis of hyperthyroidism is based on suppressed TSH and elevated fT4 (free, and in the differential diagnosis, elevated TSH-receptor-antibodies are crucial for Graves' disease. Management of Graves' disease relies on three equally potent approaches: medical therapy, ablative treatments with 131I-radiotherapy-RAI, and thyroidectomy. Hashimoto's thyroiditis is the most common cause of hypothyroidism in iodine-sufficient regions. Symptoms and signs of hypothyroidism are non-specific and correspond to the symptoms and signs of hypometabolism. The diagnosis is made based on elevated TSH with decreased fT4. Thyroxine-peroxidaseantibodies and thyroglobuline-antibodies are important in differential diagnosis. Sometimes elevated TRAb is found in Hashimoto's thyroiditis. The treatment of hypothyroidism is levothyroxine replacement therapy.
甲状腺功能障碍是人类最常见的内分泌疾病。他们经常被诊断出来,患病率在2%到6%之间,男女比例高达10:1。狭义上的甲状腺功能障碍表现为甲状腺功能亢进或不活跃,尽管存在导致甲状腺激素浓度增加的条件,但其活性却没有增加。在碘充足的地区,甲状腺功能亢进和甲状腺功能减退的最常见原因是甲状腺自身免疫性疾病。甲状腺机能亢进属于格雷夫斯病,具有典型的高代谢症状和体征。甲状腺机能亢进的诊断是基于抑制TSH和升高fT4(游离),在鉴别诊断中,升高TSH受体抗体对Graves病至关重要。格雷夫斯病的治疗依赖于三种同样有效的方法:药物治疗、131i放射治疗- rai消融治疗和甲状腺切除术。桥本甲状腺炎是碘充足地区甲状腺功能减退的最常见原因。甲状腺功能减退症的症状和体征是非特异性的,与代谢低下的症状和体征相对应。诊断是基于TSH升高和fT4降低。甲状腺素过氧化物抗体和甲状腺球蛋白抗体在鉴别诊断中具有重要意义。桥本甲状腺炎患者有时可发现TRAb升高。甲状腺功能减退症的治疗是左旋甲状腺素替代疗法。
{"title":"Thyroid function disorders","authors":"M. Stojković","doi":"10.5937/arhfarm72-39952","DOIUrl":"https://doi.org/10.5937/arhfarm72-39952","url":null,"abstract":"Thyroid function disorders are the most common endocrine disorders in humans. They are frequently diagnosed, with prevalence varying between 2 and 6%, and a female to male ratio of up to 10:1. Disorders of thyroid function in the narrower sense are presented by its hyperactivity or underactivity, although there are conditions that lead to an increased concentration of thyroid hormones, without its increased activity. In iodine-sufficient regions, the most common cause of hyperthyroidism, as well as hypothyroidism, is an autoimmune disease of the thyroid. For hyperthyroidism, it is Graves' disease, with typical symptoms and signs of hypermetabolism. The diagnosis of hyperthyroidism is based on suppressed TSH and elevated fT4 (free, and in the differential diagnosis, elevated TSH-receptor-antibodies are crucial for Graves' disease. Management of Graves' disease relies on three equally potent approaches: medical therapy, ablative treatments with 131I-radiotherapy-RAI, and thyroidectomy. Hashimoto's thyroiditis is the most common cause of hypothyroidism in iodine-sufficient regions. Symptoms and signs of hypothyroidism are non-specific and correspond to the symptoms and signs of hypometabolism. The diagnosis is made based on elevated TSH with decreased fT4. Thyroxine-peroxidaseantibodies and thyroglobuline-antibodies are important in differential diagnosis. Sometimes elevated TRAb is found in Hashimoto's thyroiditis. The treatment of hypothyroidism is levothyroxine replacement therapy.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of regulatory requirements in the US, EU and Serbia on software: Mobile application as a medical device: State of the art 审查美国、欧盟和塞尔维亚对软件的监管要求:作为医疗设备的移动应用程序:最新状况
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.5937/arhfarm72-36730
Dušan Vukmirović, I. Stević, M. Odalović, Dušanka M. Krajnović
The number of software - mobile applications intended for use in the field of people's health and well-being is constantly increasing. The aim of this review is to compare regulations on software - mobile applications as medical devices in the United States of America (USA), European Union (EU) and Serbia, with reference on the efforts for international harmonization of the regulations. The goal is to increase awareness of the broader healthcare professionals' (HCPs) audience about this topic. Publicly available information from official regulatory bodies websites was analyzed and synthesized for two regions and one country of interest. The results show differences in regulatory approaches in this area between two biggest medical device markets - the USA and the EU, while regulations in Serbia are being harmonized with the EU. Regulations clearly define criteria that software - mobile application needs to meet to be assessed as a medical device; on the other hand, they leave a number of applications that provide health-related services out of the regulated scope. Based on the increased awareness of regulations, recommendations for future research can be directed towards greater involvement of HCPs in patient counseling and decision making regarding the selection of mobile applications, to prevent the use of inadequate mobile applications and ensure that their patients are correctly using the right applications with positive effects on health and well-being.
用于人们健康和福祉领域的软件-移动应用程序的数量不断增加。本审查的目的是比较美利坚合众国(美国)、欧洲联盟(欧盟)和塞尔维亚将软件-移动应用程序作为医疗设备的法规,并参考这些法规的国际协调努力。目标是提高更广泛的医疗保健专业人员(HCPs)受众对该主题的认识。对两个区域和一个有关国家的官方管理机构网站上的公开信息进行了分析和综合。研究结果表明,美国和欧盟这两个最大的医疗器械市场在这一领域的监管方法存在差异,而塞尔维亚的监管正在与欧盟协调一致。法规明确定义了移动软件应用程序需要满足的标准,才能被评估为医疗设备;另一方面,它们将一些提供健康相关服务的应用程序排除在监管范围之外。基于对法规意识的提高,对未来研究的建议可以指向卫生保健服务提供者更多地参与患者咨询和关于选择移动应用程序的决策,以防止使用不适当的移动应用程序,并确保其患者正确使用正确的应用程序,对健康和福祉产生积极影响。
{"title":"Review of regulatory requirements in the US, EU and Serbia on software: Mobile application as a medical device: State of the art","authors":"Dušan Vukmirović, I. Stević, M. Odalović, Dušanka M. Krajnović","doi":"10.5937/arhfarm72-36730","DOIUrl":"https://doi.org/10.5937/arhfarm72-36730","url":null,"abstract":"The number of software - mobile applications intended for use in the field of people's health and well-being is constantly increasing. The aim of this review is to compare regulations on software - mobile applications as medical devices in the United States of America (USA), European Union (EU) and Serbia, with reference on the efforts for international harmonization of the regulations. The goal is to increase awareness of the broader healthcare professionals' (HCPs) audience about this topic. Publicly available information from official regulatory bodies websites was analyzed and synthesized for two regions and one country of interest. The results show differences in regulatory approaches in this area between two biggest medical device markets - the USA and the EU, while regulations in Serbia are being harmonized with the EU. Regulations clearly define criteria that software - mobile application needs to meet to be assessed as a medical device; on the other hand, they leave a number of applications that provide health-related services out of the regulated scope. Based on the increased awareness of regulations, recommendations for future research can be directed towards greater involvement of HCPs in patient counseling and decision making regarding the selection of mobile applications, to prevent the use of inadequate mobile applications and ensure that their patients are correctly using the right applications with positive effects on health and well-being.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of spray-drying process on properties of chitosan/xanthan gum polyelectrolyte complexes as carriers for oral delivery of ibuprofen 喷雾干燥工艺对布洛芬口服载体壳聚糖/黄原胶多电解质复合物性能的影响
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.5937/arhfarm72-35133
A. Ćirić, Jelena Milinković-Budinčić, Đorđe Medarević, V. Dobričić, Milena Rmandić, T. Barudžija, A. Malenović, Lidija Petrović, Ljiljana Đekić
Polyelectrolyte complexes (PECs) are attractive carriers with recognized potential to enhance oral delivery of poorly soluble high-dosed low-molecular-weight drugs. The formulation of solid oral dosage forms requires the drying of PECs, which may affect their physicochemical and biopharmaceutical properties. The aim of this study was to investigate the effect of spraydrying on the properties of ibuprofen-loaded chitosan/xanthan gum PECs and to assess the drug release kinetics from such PECs filled into hard capsules in comparison with corresponding PECs which are dried under ambient conditions. The yield, ibuprofen content, entrapment efficiency, and residual moisture content of spray-dried PECs were lower than those of ambient-dried PECs. Better flowability of spray-dried PECs was attributed to the almost spherical particle shape, shown by scanning electron microscopy. DSC and PXRD analysis confirmed the amorphization of ibuprofen during spray-drying. All the investigated PECs, obtained by drying under ambient conditions as well as by spray-drying, had high rehydration capacity both in 0.1 M hydrochloric acid (pH 1.2) and phosphate buffer pH 7.4. In vitro ibuprofen release from dried PECs was controlled during 12 h with the release of approximately 30% of entrapped ibuprofen. Spray-dried PECs provided better control of ibuprofen diffusion from the carrier compared to the ambientdried ones.
聚电解质复合物(PECs)是一种有吸引力的载体,具有增强难溶性高剂量低分子量药物口服递送的潜力。固体口服剂型的配方需要干燥的PECs,这可能会影响其物理化学和生物制药性能。本研究旨在研究喷雾干燥对布洛芬壳聚糖/黄原胶PECs性能的影响,并与常温干燥的PECs进行比较,考察其在硬胶囊内的药物释放动力学。喷雾干燥法的收率、布洛芬含量、包封效率和残留水分含量均低于环境干燥法。扫描电镜显示,喷雾干燥PECs具有较好的流动性,这主要归因于其近乎球形的颗粒形状。DSC和PXRD分析证实了布洛芬在喷雾干燥过程中的非晶化。通过常温干燥和喷雾干燥得到的PECs在0.1 M盐酸(pH 1.2)和磷酸盐缓冲液pH 7.4中均具有较高的再水化能力。在12小时内控制干燥PECs的体外布洛芬释放量,约30%的布洛芬释放量。与环境干燥的PECs相比,喷雾干燥的PECs可以更好地控制布洛芬从载体扩散。
{"title":"Influence of spray-drying process on properties of chitosan/xanthan gum polyelectrolyte complexes as carriers for oral delivery of ibuprofen","authors":"A. Ćirić, Jelena Milinković-Budinčić, Đorđe Medarević, V. Dobričić, Milena Rmandić, T. Barudžija, A. Malenović, Lidija Petrović, Ljiljana Đekić","doi":"10.5937/arhfarm72-35133","DOIUrl":"https://doi.org/10.5937/arhfarm72-35133","url":null,"abstract":"Polyelectrolyte complexes (PECs) are attractive carriers with recognized potential to enhance oral delivery of poorly soluble high-dosed low-molecular-weight drugs. The formulation of solid oral dosage forms requires the drying of PECs, which may affect their physicochemical and biopharmaceutical properties. The aim of this study was to investigate the effect of spraydrying on the properties of ibuprofen-loaded chitosan/xanthan gum PECs and to assess the drug release kinetics from such PECs filled into hard capsules in comparison with corresponding PECs which are dried under ambient conditions. The yield, ibuprofen content, entrapment efficiency, and residual moisture content of spray-dried PECs were lower than those of ambient-dried PECs. Better flowability of spray-dried PECs was attributed to the almost spherical particle shape, shown by scanning electron microscopy. DSC and PXRD analysis confirmed the amorphization of ibuprofen during spray-drying. All the investigated PECs, obtained by drying under ambient conditions as well as by spray-drying, had high rehydration capacity both in 0.1 M hydrochloric acid (pH 1.2) and phosphate buffer pH 7.4. In vitro ibuprofen release from dried PECs was controlled during 12 h with the release of approximately 30% of entrapped ibuprofen. Spray-dried PECs provided better control of ibuprofen diffusion from the carrier compared to the ambientdried ones.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Antiarrhythmic effects of newly developed propafenone derivatives 新开发的普罗帕酮衍生物的抗心律失常作用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.5937/arhfarm72-37114
B. Ivković, D. Opačić, B. Dzudovic, Milkica Crevar, L. Gojković-Bukarica
It is well known that the presence of different chemical groups in drug molecules influences their pharmacological properties. The aim of our study is to investigate whether newly synthesized derivatives of propafenone, with changes in benzyl moiety, have a different effect upon arrhythmia, compared to propafenone. 5OCl-PF and 5OF-PF are derivatives of propafenone with -Cl or -F substituent on the ortho position of the benzyl moiety. For verification of their antiarrhythmic effect, we used an in vivo rat model of aconitine-induced arrhythmia. 5OCl-PF speeded the appearance of supraventricular premature beats (SVPB) and death more than aconitine. All animals treated with 5OCl-PF developed ventricular premature beats in salvos (VPBS), bigeminies (VPBB) and paroxysmal ventricular tachycardia (PVT). 5OF-PF had a negative chronotropic effect and potentiated atrial excitability (more SVPB). It had a positive effect on the occurrence and onset time of supraventricular tachycardia, VPBS, and PVT. Based on the obtained results, it can be concluded that newly synthesized propafenone derivatives have no better antiarrhythmic effect than the parent compound. In the future, our research will be focused on the synthesis of different derivatives and examining their antiarrhythmic effects.
众所周知,药物分子中不同化学基团的存在会影响其药理学性质。我们的研究目的是探讨新合成的普罗帕酮衍生物,其苯基部分的变化是否与普罗帕酮对心律失常的影响不同。5OCl-PF和5OF-PF是在苯基部分的邻位上具有-Cl或-F取代基的普罗帕酮衍生物。为了验证其抗心律失常的作用,我们使用了乌头碱诱发心律失常的体内大鼠模型。5OCl-PF比乌头碱更能加速室上性早搏(SVPB)的出现和死亡。所有接受5OCl-PF治疗的动物均出现齐射性室性早搏(VPBS)、双心室性早搏(VPBB)和阵发性室性心动过速(PVT)。5OF-PF具有负变时作用,增强心房兴奋性(更多的SVPB)。对室上性心动过速、VPBS、ptt的发生及起病时间均有积极影响。根据所得结果,新合成的propaenone衍生物的抗心律失常作用并不优于母体化合物。在未来,我们的研究将集中在不同衍生物的合成和研究其抗心律失常的作用。
{"title":"Antiarrhythmic effects of newly developed propafenone derivatives","authors":"B. Ivković, D. Opačić, B. Dzudovic, Milkica Crevar, L. Gojković-Bukarica","doi":"10.5937/arhfarm72-37114","DOIUrl":"https://doi.org/10.5937/arhfarm72-37114","url":null,"abstract":"It is well known that the presence of different chemical groups in drug molecules influences their pharmacological properties. The aim of our study is to investigate whether newly synthesized derivatives of propafenone, with changes in benzyl moiety, have a different effect upon arrhythmia, compared to propafenone. 5OCl-PF and 5OF-PF are derivatives of propafenone with -Cl or -F substituent on the ortho position of the benzyl moiety. For verification of their antiarrhythmic effect, we used an in vivo rat model of aconitine-induced arrhythmia. 5OCl-PF speeded the appearance of supraventricular premature beats (SVPB) and death more than aconitine. All animals treated with 5OCl-PF developed ventricular premature beats in salvos (VPBS), bigeminies (VPBB) and paroxysmal ventricular tachycardia (PVT). 5OF-PF had a negative chronotropic effect and potentiated atrial excitability (more SVPB). It had a positive effect on the occurrence and onset time of supraventricular tachycardia, VPBS, and PVT. Based on the obtained results, it can be concluded that newly synthesized propafenone derivatives have no better antiarrhythmic effect than the parent compound. In the future, our research will be focused on the synthesis of different derivatives and examining their antiarrhythmic effects.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71198905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet? SMAC模拟物在癌症中的进展和前景综述:它是灵丹妙药吗?
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.5937/arhfarm72-39318
E. Almuradova, Durr-e-shahwar Malik, Sara Yousaf, A. Farooqi
Loss of apoptosis results in the survival and uncontrolled proliferation of cancer cells. Basic and clinical researchers have dissected myriads of central regulators of apoptosis. Second mitochondria-derived activator of caspases (SMAC)/ direct inhibitor of apoptosis protein (IAP)-binding protein with low pI (DIABLO) has attracted phenomenal attention because of its amazing ability to trigger apoptotic death. Accordingly, different teams of interdisciplinary researchers are working on the design and development of SMAC mimetics which can significantly inhibit primary and secondary tumor growth.
细胞凋亡的缺失导致癌细胞的存活和不受控制的增殖。基础和临床研究人员已经解剖了无数细胞凋亡的中枢调节因子。第二线粒体源性半胱天蛋白酶激活剂(SMAC)/低pI直接抑制凋亡蛋白(IAP)结合蛋白(DIABLO)因其引发凋亡死亡的惊人能力而引起了人们的极大关注。因此,不同的跨学科研究团队正在设计和开发能够显著抑制原发性和继发性肿瘤生长的SMAC模拟物。
{"title":"Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet?","authors":"E. Almuradova, Durr-e-shahwar Malik, Sara Yousaf, A. Farooqi","doi":"10.5937/arhfarm72-39318","DOIUrl":"https://doi.org/10.5937/arhfarm72-39318","url":null,"abstract":"Loss of apoptosis results in the survival and uncontrolled proliferation of cancer cells. Basic and clinical researchers have dissected myriads of central regulators of apoptosis. Second mitochondria-derived activator of caspases (SMAC)/ direct inhibitor of apoptosis protein (IAP)-binding protein with low pI (DIABLO) has attracted phenomenal attention because of its amazing ability to trigger apoptotic death. Accordingly, different teams of interdisciplinary researchers are working on the design and development of SMAC mimetics which can significantly inhibit primary and secondary tumor growth.","PeriodicalId":39173,"journal":{"name":"Arhiv za Farmaciju","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71199098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arhiv za Farmaciju
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1